BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ORION Biotech Catalyst Calendar//company//EN
CALSCALE:GREGORIAN
X-WR-CALNAME:ORION — SNY stated timing
X-WR-CALDESC:Exact dates SNY stated in SEC filings\, quoted as written\, wi
 th SEC links. No forecasts.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:orion-event-FDA20261030-SNY-FDA-DECISION@orionbiotechai.com
SEQUENCE:1
DTSTAMP:20261029T000000Z
LAST-MODIFIED:20261029T000000Z
DTSTART;VALUE=DATE:20261125
DTEND;VALUE=DATE:20261126
SUMMARY:SNY venglustat: FDA decision\, “November 25\, 2026”
DESCRIPTION:Sanofi (SNY)\, venglustat: PDUFA target action date.\nCompany w
 ording\, as written: “The target action date for the FDA decision is Nov
 ember 25\, 2026.”\nStated period: “November 25\, 2026”.\nFiled 2026-
 07-30\, SEC Form 6-K\, EX-99.1.\nSEC filing: https://www.sec.gov/Archives/
 edgar/data/1121404/000112140426000008/pressreleaseq22026english.htm\nORION
  page: https://www.orionbiotechai.com/company/SNY?src=ics\nORION records w
 hat the company wrote. It is not a forecast.
URL:https://www.orionbiotechai.com/company/SNY?src=ics
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR